D. E. Shaw & Co., Inc. Corcept Therapeutics Inc Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 788,064 shares of CORT stock, worth $40.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

788,064

Holding current value

$40.5 Million

% of portfolio

0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $4.75 Million - $7.45 Million	-161,079 Reduced 16.97%	788,064 $36.5 Million
Q2 2024 Aug 14, 2024	SELL	$22.21 - $34.48 $4.09 Million - $6.34 Million	-183,941 Reduced 16.23%	949,143 $30.8 Million
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $11.1 Million - $14.4 Million	-525,554 Reduced 31.69%	1,133,084 $28.5 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $3.49 Million - $4.62 Million	140,531 Added 9.26%	1,658,638 $53.9 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $8.1 Million - $12.5 Million	368,458 Added 32.05%	1,518,107 $41.4 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $7.84 Million - $9.19 Million	365,450 Added 46.6%	1,149,649 $25.6 Million
Q1 2023 May 15, 2023	SELL	$19.2 - $24.47 $7.84 Million - $9.99 Million	-408,159 Reduced 34.23%	784,199 $17 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $8.37 Million - $12.6 Million	-419,466 Reduced 26.02%	1,192,358 $24.2 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $9,978 - $11,764	404 Added 0.03%	1,611,824 $41.3 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $8.54 Million - $12.5 Million	492,709 Added 44.04%	1,611,420 $38.3 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $12 Million - $18.3 Million	724,963 Added 184.12%	1,118,711 $25.2 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $2.87 Million - $3.92 Million	168,071 Added 74.47%	393,748 $7.8 Million
Q3 2021 Nov 15, 2021	BUY	$19.68 - $22.53 $1.75 Million - $2 Million	88,821 Added 64.9%	225,677 $4.44 Million
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $2.96 Million - $3.62 Million	-148,261 Reduced 52.0%	136,856 $3.01 Million
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $6.03 Million - $7.84 Million	-256,642 Reduced 47.37%	285,117 $6.78 Million
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $1.95 Million - $3.17 Million	116,192 Added 27.3%	541,759 $14.2 Million
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $1.26 Million - $2.01 Million	100,813 Added 31.04%	425,567 $7.41 Million
Q2 2020 Aug 14, 2020	BUY	$11.0 - $18.26 $445,687 - $739,840	40,517 Added 14.25%	324,754 $5.46 Million
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $198,327 - $275,422	19,617 Added 7.41%	284,237 $3.38 Million
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $1.35 Million - $1.9 Million	-112,113 Reduced 29.76%	264,620 $3.2 Million
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $2.12 Million - $2.99 Million	203,976 Added 118.07%	376,733 $5.33 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $1.57 Million - $2.05 Million	160,485 Added 1307.73%	172,757 $1.93 Million
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $5.2 Million - $8.15 Million	-518,511 Reduced 97.69%	12,272 $144,000
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $4.53 Million - $6.9 Million	401,493 Added 310.54%	530,783 $7.09 Million
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $1.59 Million - $2.02 Million	129,290 New	129,290 $1.81 Million
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $901,598 - $1.16 Million	-58,928 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $919,126 - $1.61 Million	-62,997 Reduced 51.67%	58,928 $969,000
Q4 2017 Feb 14, 2018	SELL	$15.77 - $20.72 $3.44 Million - $4.52 Million	-218,193 Reduced 64.15%	121,925 $2.2 Million
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $4.18 Million - $6.56 Million	340,118	340,118 $6.56 Million

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.51B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account